Monday, Nov 25, 2024 · SEC filings
What the smart money revealed on Nov 25
530 insider filings came in. We hid 74 planned (10b5-1) sellers and 235 people whose filings were routine, like grants and tax withholding.
3 insiders at Immunome (IMNM) bought $1.31M of stock
Roles: CEO, CTO, Chief Medical Officer. Several insiders buying in the same few days is rare.
Prospect Capital (PSEC) CEO John Barry bought $4.64M
1M shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.
United Parks & Resorts (PRKS) Officer James Mikolaichik bought $1.95M
34,000 shares on the open market. Not a grant or an option exercise.
Neurogene (NGNE) CEO Rachel McMinn bought $969K
47,500 shares on the open market. Not a grant or an option exercise.
Ventyx Biosciences (VTYX) CEO and President Raju Mohan bought $962K
500,000 shares on the open market. Not a grant or an option exercise.
Gulfport Energy (GPOR) Director Robert O'Shea sold $83M
Not marked as a planned 10b5-1 sale. Sold 11% of the shares they held directly. Still holds 3.76M shares.
Innodata (INOD) CEO and President Jack Abuhoff sold $25.6M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 2.38M shares directly.
Ibotta (IBTA) Director Thomas Lehrman sold $4.57M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 50 more real buys
Show 125 more real sales
13F season
Holdings as of Sep 30, 2024 were due Nov 14
58 funds have filed. 54 filed for the quarter before.
Biggest real insider buys, Nov 19–25
Open-market buys by officers and directors, filed in the 7 days up to Nov 25.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.